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Surgical versus Nonsurgical Therapy
for Lumbar Spinal Stenosis
James N. Weinstein, D.O., M.S., Tor D. Tosteson, Sc.D., Jon D. Lurie, M.D., M.S.,
Anna N.A. Tosteson, Sc.D., Emily Blood, M.S., Brett Hanscom, M.S.,
Harry Herkowitz, M.D., Frank Cammisa, M.D., Todd Albert, M.D.,
Scott D. Boden, M.D., Alan Hilibrand, M.D., Harley Goldberg, D.O.,
Sigurd Berven, M.D., and Howard An, M.D., for the SPORT Investigators*

A bs t r ac t
Background
From the Departments of Orthopedics
(J.N.W., E.B., B.H.), Community and Fam
ily Medicine (T.D.T., J.D.L., A.N.A.T.), and
Medicine (J.D.L., A.N.A.T.), Dartmouth
Medical School, Hanover, NH, and Dart
mouth–Hitchcock Medical Center, Leba
non, NH; William H. Beaumont Hospital,
Royal Oak, MI (H.H.); Hospital for Spe
cial Surgery, New York (F.C.); Rothman
Institute at Thomas Jefferson University,
Philadelphia (T.A., A.H.); Emory Spine Cen
ter, Emory University, Atlanta (S.D.B.);
Kaiser Permanente, San Francisco (H.G.);
University of California at San Francisco,
San Francisco (S.B.); and Rush–Presbyte
rian–St. Luke’s Medical Center, Chicago
(H.A.). Address reprint requests to Dr.
Weinstein at the Dartmouth Institute for
Health Policy and Clinical Practice, Depart
ment of Orthopedics, Dartmouth Medical
School, 1 Medical Center Dr., Lebanon,
NH 03756, or at sport@dartmouth.edu.
*Investigators in the Spine Patient Out
comes Research Trial (SPORT) are listed
in the Appendix.
N Engl J Med 2008;358:794-810.
Copyright © 2008 Massachusetts Medical Society.

Surgery for spinal stenosis is widely performed, but its effectiveness as compared
with nonsurgical treatment has not been shown in controlled trials.
Methods

Surgical candidates with a history of at least 12 weeks of symptoms and spinal
stenosis without spondylolisthesis (as confirmed on imaging) were enrolled in either
a randomized cohort or an observational cohort at 13 U.S. spine clinics. Treatment
was decompressive surgery or usual nonsurgical care. The primary outcomes were
measures of bodily pain and physical function on the Medical Outcomes Study 36-item
Short-Form General Health Survey (SF-36) and the modified Oswestry Disability
Index at 6 weeks, 3 months, 6 months, and 1 and 2 years.
Results

A total of 289 patients were enrolled in the randomized cohort, and 365 patients
were enrolled in the observational cohort. At 2 years, 67% of patients who were
randomly assigned to surgery had undergone surgery, whereas 43% of those who
were randomly assigned to receive nonsurgical care had also undergone surgery.
Despite the high level of nonadherence, the intention-to-treat analysis of the randomized cohort showed a significant treatment effect favoring surgery on the SF-36
scale for bodily pain, with a mean difference in change from baseline of 7.8 (95%
confidence interval, 1.5 to 14.1); however, there was no significant difference in
scores on physical function or on the Oswestry Disability Index. The as-treated
analysis, which combined both cohorts and was adjusted for potential confounders,
showed a significant advantage for surgery by 3 months for all primary outcomes;
these changes remained significant at 2 years.
Conclusions

In the combined as-treated analysis, patients who underwent surgery showed significantly more improvement in all primary outcomes than did patients who were
treated nonsurgically. (ClinicalTrials.gov number, NCT00000411.)
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S

pinal stenosis is a narrowing of the
spinal canal with encroachment on the neural structures by surrounding bone and soft
tissue. Patients typically present with radicular leg
pain or with neurogenic claudication (pain in the
buttocks or legs on walking or standing that resolves with sitting down or lumbar flexion). Spinal stenosis is the most common reason for lumbar spine surgery in adults over the age of 65
years.1,2 Indications for surgery appear to vary
widely, and rates of procedures vary by at least a
factor of 5 across geographic areas.3,4 Radiographic evidence of stenosis is frequently asymptomatic; thus, careful clinical correlation between
symptoms and imaging is critical.5,6
A 2005 Cochrane review found that the paucity and heterogeneity of evidence limited conclusions regarding surgical efficacy for spinal stenosis. The trials comparing surgical with nonsurgical
treatment were generally small and involved patients both with and without degenerative spondylolisthesis.7-12 We know of no randomized
trials of isolated spinal stenosis without degenerative spondylolisthesis.
In the Spine Patient Outcomes Research Trial
(SPORT), we report on the 2-year outcomes of
patients with spinal stenosis without degenerative spondylolisthesis to analyze the relative efficacy of surgical versus nonsurgical treatment.

showing lumbar spinal stenosis at one or more
levels; all patients were judged to be surgical candidates. Patients with degenerative spondylolisthesis were studied separately.16 Patients with
lumbar instability (which was defined as translation of more than 4 mm or 10 degrees of angular
motion between flexion and extension on upright
lateral radiographs) were excluded. The type of
nonsurgical care before enrollment was not prespecified but included physical therapy (68% of
patients), epidural injections (56%), chiropractic
(28%), the use of antiinflammatory drugs (55%),
and the use of opioid analgesics (27%).
Research nurses at each site verified eligibility. Patients were offered enrollment in either co
hort. To aid in obtaining written informed consent, patients viewed evidence-based videotapes
with standardized information regarding alternative treatments.20,21 Patients in the randomized
cohort received treatment assignments with the
use of randomly permuted blocks with variable
block sizes stratified according to center. Patients
in the observational cohort chose their treatment
at enrollment with their physician. Enrollment be
gan in March 2000 and ended in March 2005.
Study Interventions

The protocol surgery was standard posterior decompressive laminectomy.13 The nonsurgical protocol was “usual care,” which was recommended
to include at least active physical therapy, educaMe thods
tion or counseling with home exercise instruction,
Study Design
and the administration of nonsteroidal antiinflamSPORT was an investigator-initiated study con- matory drugs, if tolerated.13,18
ducted in 11 states at 13 U.S. medical centers
with multidisciplinary spine practices. The study Study Measures
included both a randomized cohort and a con- Primary outcomes were measures of bodily pain
current observational cohort of patients who de- and physical function on the Medical Outcomes
clined to undergo randomization.13-16 This de- Study 36-item Short-Form General Health Survey
sign allowed for improved generalizability of the (SF-36)22-25 and on the modified Oswestry Disfindings.17 The ethics committee at each partici- ability Index (American Academy of Orthopaedic
pating institution approved a standardized pro- Surgeons–MODEMS [Musculoskeletal Outcomes
tocol. An independent data and safety monitoring Data Evaluation and Management Systems] verboard evaluated interim safety and efficacy out- sion),26 measured at 6 weeks, 3 months, 6 months,
comes at 6-month intervals.13-16,18 Stopping rules and 1 and 2 years. (SF-36 scores range from 0 to
were provided on the basis of the alpha spending 100, with higher scores indicating less severe
function of DeMets and Lan.19
symptoms. The Oswestry Disability Index ranges
from 0 to 100, with lower scores indicating less
Patient Population
severe symptoms.)
All patients had a history of neurogenic claudicaIf surgery was delayed beyond 6 weeks, addition or radicular leg symptoms for at least 12 tional follow-up data were obtained at 6 weeks
weeks and confirmatory cross-sectional imaging and at 3 months after surgery. Secondary outn engl j med 358;8
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comes included patient-reported improvement,
satisfaction with current symptoms and care,27
and the bothersomeness of both stenosis7,28 and
low back pain.7 The effect of treatment was defined as the difference in the mean change from
baseline between the surgical group and the nonsurgical group.
Statistical Analysis

For the randomized cohort, we determined that
a sample size of 185 per group was needed to
detect a 10-point difference in bodily pain and
physical function on the SF-36 or a similar effect
on the Oswestry Disability Index13 on the basis
of a t-test, with a two-sided significance level of
0.05 and a power of 85%. Standard deviations for
changes from baseline were derived from pilot
data on repeated visits. The sample-size calculation allowed for 20% missing data but did not
account for any specific levels of nonadherence.
Initial analyses compared the baseline characteristics of patients in the randomized cohort
with those in the observational cohort and between study groups in the combined cohorts. The
extent of missing data and the percentage of patients undergoing surgery were calculated according to study group for each scheduled follow-up.
Baseline predictors of the time until surgical
treatment (including treatment crossovers) in both
cohorts were determined through a stepwise proportional-hazards regression model with an inclu
sion criterion of P<0.1 to enter and P>0.05 to exit.
Predictors of missing follow-up visits at 1 year
were determined through stepwise logistic regression.
Primary analyses compared surgical and nonsurgical treatments with the use of changes from
baseline at each follow-up visit, with a mixedeffects model of longitudinal regression that included a random individual effect to account for
correlation between repeated measurements. The
randomized cohort was initially analyzed on an
intention-to-treat basis. Because of crossover, sub
sequent analyses were based on treatments actually received. In the as-treated analyses, the treatment indicator was a time-varying covariate,
allowing for variable times of surgery. For the
intention-to-treat analyses, all times are from en
rollment. For the as-treated analysis, the times
are from the beginning of treatment (i.e., the
time of surgery for the surgical group and the
time of enrollment for the nonsurgical group).
796
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Therefore, all changes from baseline before surgery were included in the estimates of the nonsurgical treatment effect. After surgery, changes
were assigned to the surgical group, with followup measured from the date of surgery. Repeated
measures of outcomes were used as the dependent variables, and treatment received was includ
ed as a time-varying covariate. Adjustments were
made for the time of surgery with respect to the
original enrollment date so as to approximate the
designated follow-up times.
The randomized and observational cohorts
were each analyzed to produce separate as-treat
ed estimates of treatment effect. These results
were compared with the use of a Wald test to
simultaneously test all follow-up visit times for
differences in estimated treatment effects between the two cohorts.29 Subsequent analyses
combined the two cohorts.
To adjust for potential confounding, baseline
variables that were associated with missing data
or treatment received were included as adjusting
covariates in longitudinal regression models.29
Computations were performed with the use of
the PROC MIXED procedure for continuous data
and the PROC GENMOD procedure for binary
and non-normal secondary outcomes in SAS
software, version 9.1 (SAS Institute). Statistical
significance was defined as P<0.05 on the basis
of a two-sided hypothesis test with no adjustments made for multiple comparisons. Data for
these analyses were collected through March
2, 2007.

R e sult s
Patients

A total of 654 patients were enrolled out of 1091
who were eligible for enrollment: 289 in the randomized cohort and 365 in the observational cohort (Fig. 1). In the randomized cohort, 138 patients were assigned to the surgical group, and
151 were assigned to the nonsurgical group. In
the surgery group, 63% had undergone surgery
at 1 year and 67% at 2 years. In the nonsurgical
group, 42% had undergone surgery at 1 year and
Figure 1 (facing page). Enrollment, Randomization,
and Follow-up.
The numbers of patients who withdrew from the study,
died, or underwent surgery are cumulative during the
2-year follow-up period.
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1696 Patients were screened

605 Were ineligible
277 Were not surgical candidates
90 Had fracture, infection, or deformity
78 Had inadequate nonsugical treatment
41 Had cancer
119 Had other reasons

1091 Were eligible

437 Declined to participate

289 Were enrolled in the
randomized cohort

365 Were enrolled in the
observational cohort

151 Were assigned to
nonsurgical treatment

138 Were assigned to surgery

116 Were available at 6 wk
20 Missed the follow-up visit
2 Withdrew

219 Chose surgery

130 Were available at 6 wk
21 Missed the follow-up visit

185 Were available at 6 wk
31 Missed the follow-up visit
2 Withdrew
1 Died

12 (8%) Had undergone surgery

146 Chose nonsurgical
treatment

134 Were available at 6 wk
12 Missed the follow-up visit
0 Had undergone surgery

25 (18%) Had undergone surgery
173 (79%) Had undergone surgery

116 Were available at 3 mo
19 Missed the follow-up visit
3 Withdrew

135 Were available at 3 mo
15 Missed the follow-up visit
1 Withdrew

58 (42%) Had undergone surgery

185 Were available at 3 mo
31 Missed the follow-up visit
2 Withdrew
1 Died

34 (23%) Had undergone surgery

130 Were available at 3 mo
14 Missed the follow-up visit
2 Withdrew
5 (3%) Had undergone surgery

197 (90%) Had undergone surgery

120 Were available at 6 mo
13 Missed the follow-up visit
4 Withdrew
1 Died

135 Were available at 6 mo
10 Missed the follow-up visit
6 Withdrew

195 Were available at 6 mo
19 Missed the follow-up visit
4 Withdrew
1 Died

54 (36%) Had undergone surgery

14 (10%) Had undergone surgery

74 (54%) Had undergone surgery

120 Were available at 1 yr
9 Missed the follow-up visit
8 Withdrew
1 Died

133 Were available at 6 mo
9 Missed the follow-up visit
4 Withdrew

204 (93%) Had undergone surgery

126 Were available at 1 yr
14 Missed the follow-up visit
9 Withdrew
2 Died

198 Were available at 1 yr
15 Missed the follow-up visit
5 Withdrew
1 Died

139 Were available at 1 yr
2 Missed the follow-up visit
5 Withdrew
25 (17%) Had undergone surgery

87 (63%) Had undergone surgery

108 Were available at 2 yr
14 Missed the follow-up visit
11 Withdrew
3 Died
2 Had pending visit

63 (42%) Had undergone surgery

208 (95%) Had undergone surgery

113 Were available at 2 yr
14 Missed the follow-up visit
19 Withdrew
4 Died
1 Had pending visit

188 Were available at 2 yr
15 Missed the follow-up visit
14 Withdrew
2 Died
211 (96%) Had undergone surgery

92 (67%) Had undergone surgery

132 Were available at 2 yr
5 Missed the follow-up visit
8 Withdrew
1 Died
32 (22%) Had undergone surgery

65 (43%) Had undergone surgery
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43% at 2 years. In the observational cohort, 219
patients initially chose surgery and 146 patients
initially chose nonsurgical care. Of those who
initially chose surgery, 95% had undergone surgery at 1 year and 96% at 2 years. Of those who
initially chose nonsurgical treatment, 17% had
undergone surgery at 1 year and 22% at 2 years.
In the two cohorts combined, 400 patients received surgery at some point during the first
2 years, and 254 received nonsurgical treatment.
The proportion of enrollees who supplied data
at each follow-up interval ranged from 83 to 89%,
with losses due to dropouts, missed visits, or
deaths. A total of 634 patients, each with at least
one follow-up through 2 years, were included in
the analysis, including 278 patients (96%) in the
randomized cohort and 356 patients (98%) in the
observational cohort.

At 2 years, nonsurgical treatments were similar
in the two cohorts. However, more patients in the
randomized group than in the observational group
reported visits to a surgeon (45% vs. 32%, P = 0.02)
and receiving injections (52% vs. 39%, P = 0.02),
whereas more patients in the observational group
reported the use of “other” medications, such as
gabapentin (60% vs. 73%, P = 0.01).

Characteristics of the Patients

Surgical Treatments and Complications

Characteristics of the patients at baseline in the
two cohorts are compared in Table 1. Overall,
the cohorts were similar. However, patients in
the observational cohort had more signs of nerveroot tension and less lateral recess stenosis and
expressed stronger treatment preferences than did
patients in the randomized cohort.
Summary statistics for the combined cohorts
are also shown in Table 1, according to treatment received. The study population had a mean
age of 65 years; a majority were white men who
had attended college. Of these patients, 80% had
classic neurogenic claudication, and 79% had associated dermatomal pain radiation; 91% had
stenosis at L4 or L5, and 61% had more than one
level of stenosis. For most patients, the overall
stenosis was graded as severe.
At baseline, the group undergoing surgery was
younger and more likely to be working than was
the group that did not undergo surgery. Patients
in the surgical group had more pain, a lower
level of function, more psychological distress,
and more self-reported disability than did patients
in the nonsurgical group. In addition, patients in
the surgical group had symptoms that were more
bothersome and radiographic evidence of more
severe stenosis. The surgical group was more often dissatisfied with their symptoms and more
often rated the symptoms as worsening than did
patients in the nonsurgical group.

Overall, surgical treatments and complications
were similar in the two cohorts (Table 2). Among
patients in the surgical group, 89% underwent
decompression only. Instrumented fusion was
performed in only 6% of patients. The median
surgical time was 120 minutes, with a mean
blood loss of 314 ml; 10% of patients required
transfusions intraoperatively and 5% postoperatively. The most common surgical complication
was dural tear, in 9% of patients. At 2 years, reoperation had occurred in 8% of patients; fewer
than half of these operations were for recurrent
stenosis.
At 2 years, there were seven deaths in the
nonsurgical group and six in the surgical group,
one of which occurred within 3 months after
surgery. The deaths were reviewed and 12 were
judged not to be treatment-related. The one
death of unknown cause occurred 501 days after
surgery.

n engl j med 358;8

The final models, combining both cohorts,
were adjusted for age, sex, coexisting disorders of
the stomach or joints, the presence or absence
of pain on straight-leg raising or femoral-nerve
tension signs, smoking status, patient-assessed
health trend, income, other compensation, bodymass index, baseline score for the outcome variable, and center.
Nonsurgical Treatments

Crossover

Nonadherence to treatment assignment affected
both study cohorts: some patients in the surgical
group chose to delay or decline surgery, and some
in the nonsurgical group crossed over to undergo
surgery (Fig. 1). The characteristics of crossover
patients that differed significantly from patients
who did not cross over are shown in Table 3.
Patients in the nonsurgical group who crossed
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Table 1. Demographic Characteristics, Coexisting Illnesses, and Measures of Health Status of the Patients.*
Variable

SPORT Study Cohort
Randomized
Group
(N = 278)

Observational
Group
(N = 356)

65.5±10.5

63.9±12.5

106 (38)

Non-Hispanic
White

Combined Randomized and Observational Cohorts

P Value

Surgical
Group
(N = 394)

Nonsurgical
Group
(N = 240)

P Value

0.10

63.6±12.2

66.3±10.5

0.004

143 (40)

0.66

152 (39)

97 (40)

0.71

259 (93)

346 (97)

0.03

378 (96)

227 (95)

0.55

238 (86)

295 (83)

0.41

332 (84)

201 (84)

0.95

Attended college — no. (%)

176 (63)

225 (63)

0.96

245 (62)

156 (65)

0.53

Married — no. (%)

197 (71)

249 (70)

0.87

288 (73)

158 (66)

0.06

Age — yr
Female sex — no. (%)
Race or ethnic background — no. (%)†

Employment status — no. (%)

0.12

0.05

Full-time or part-time

88 (32)

128 (36)

144 (37)

72 (30)

Disabled

24 (9)

36 (10)

40 (10)

20 (8)

Retired

144 (52)

152 (43)

167 (42)

129 (54)

Other

22 (8)

40 (11)

43 (11)

19 (8)

Disability compensation — no. (%)‡
Body-mass index§
Current smoker — no. (%)

21 (8)

27 (8)

0.89

30 (8)

18 (8)

0.92

29.8±5.6

29.3±5.6

0.31

29.3±5.3

29.9±6.1

0.25

34 (12)

28 (8)

0.09

36 (9)

26 (11)

0.58

Coexisting condition — no. (%)
Hypertension

134 (48)

154 (43)

0.25

168 (43)

120 (50)

0.09

Diabetes

50 (18)

46 (13)

0.10

53 (13)

43 (18)

0.16

Osteoporosis

22 (8)

38 (11)

0.30

30 (8)

30 (12)

0.06

Heart disorder

80 (29)

85 (24)

0.19

95 (24)

70 (29)

0.19

Stomach disorder

60 (22)

79 (22)

0.93

82 (21)

57 (24)

0.44

Bowel or intestinal disorder

36 (13)

50 (14)

0.78

49 (12)

37 (15)

0.35

Depression

36 (13)

34 (10)

0.22

41 (10)

29 (12)

0.60

158 (57)

188 (53)

0.35

210 (53)

136 (57)

0.46

95 (34)

125 (35)

0.87

136 (35)

84 (35)

0.97

158 (57)

210 (59)

0.64

236 (60)

132 (55)

0.26

Joint disorder
Other disorder¶
Symptom duration >6 mo — no. (%)
SF-36 score‖
Bodily pain

31.9±17.5

31.4±17.4

0.73

28.6±16.2

36.6±18.4

<0.001

Physical function

35.4±22.6

34.3±23.8

0.55

31.7±21.9

39.9±24.5

<0.001

Mental component summary

49.8±12.4

49.1±11.6

0.47

48.5±12.0

50.9±11.7

0.02

Oswestry Disability Index**

42.7±17.9

42.1±19.0

0.70

46.0±17.9

36.4±17.9

<0.001

Stenosis Frequency Index††

13.5±5.7

14.2±5.8

0.13

15.2±5.6

11.8±5.6

<0.001

Stenosis Bothersomeness Index‡‡

13.9±5.7

14.7±5.8

0.08

15.6±5.4

12.3±5.7

<0.001

Low Back Pain Bothersomeness Scale§§

4.0±1.9

4.2±1.8

0.19

4.3±1.8

3.8±1.8

0.002

Leg Pain Bothersomeness Scale¶¶

4.3±1.7

4.4±1.7

0.44

4.6±1.6

3.9±1.8

<0.001

Patient very dissatisfied with symptoms
— no. (%)

183 (66)

250 (70)

0.27

309 (78)

124 (52)

<0.001
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Table 1. (Continued.)
Variable

SPORT Study Cohort
Randomized
Group
(N = 278)

Observational
Group
(N = 356)

Combined Randomized and Observational Cohorts

P Value

Surgical
Group
(N = 394)

Nonsurgical
Group
(N = 240)

0.48

Patient’s self-assessed health trend
— no. (%)

<0.001

Problem getting better

18 (6)

28 (8)

14 (4)

32 (13)

Problem staying about the same

95 (34)

108 (30)

108 (27)

95 (40)

160 (58)

218 (61)

265 (67)

113 (47)

Problem getting worse
Treatment preference — no. (%)

P Value

<0.001

<0.001

Nonsurgical
Definitely
Probably

37 (13)

86 (24)

36 (9)

87 (36)

61 (22)

45 (13)

36 (9)

70 (29)

95 (34)

26 (7)

61 (15)

60 (25)

Definitely

33 (12)

163 (46)

188 (48)

8 (3)

Probably

51 (18)

36 (10)

73 (19)

14 (6)

219 (79)

289 (81)

0.51

317 (80)

191 (80)

0.87

41 (15)

91 (26)

0.001

85 (22)

47 (20)

0.62

Dermatomal pain radiation

215 (77)

284 (80)

0.52

310 (79)

189 (79)

0.94

Any neurologic deficit

Not sure
Surgical

Signs and symptoms — no. (%)
Neurogenic claudication
Pain on straight-leg raising or
femoral-nerve tension sign

146 (53)

203 (57)

0.29

210 (53)

139 (58)

0.29

Asymmetric depressed reflexes

76 (27)

92 (26)

0.74

102 (26)

66 (28)

0.72

Asymmetric decrease in sensory
reflexes

68 (24)

114 (32)

0.05

116 (29)

66 (28)

0.66

Asymmetric motor weakness

71 (26)

106 (30)

0.28

104 (26)

73 (30)

0.32

Stenosis level — no. (%)
L2–L3

77 (28)

102 (29)

0.86

121 (31)

58 (24)

0.09

L3–L4

183 (66)

237 (67)

0.91

266 (68)

154 (64)

0.44

L4–L5

255 (92)

324 (91)

0.86

362 (92)

217 (90)

0.63

L5–S1

72 (26)

101 (28)

0.55

100 (25)

73 (30)

0.20

Moderate or severe stenotic levels —
no. (%)

0.45

0.19

0

4 (1)

11 (3)

6 (2)

9 (4)

1

106 (38)

128 (36)

140 (36)

94 (39)

2

109 (39)

132 (37)

153 (39)

88 (37)

≥3

59 (21)

85 (24)

95 (24)

49 (20)

Central

241 (87)

302 (85)

0.58

338 (86)

205 (85)

0.99

Lateral recess

236 (85)

267 (75)

0.003

321 (81)

182 (76)

0.11

Neuroforamen

88 (32)

119 (33)

0.70

119 (30)

88 (37)

0.11

Location of stenosis — no. (%)
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Table 1. (Continued.)
Variable

SPORT Study Cohort
Randomized
Group
(N = 278)

Observational
Group
(N = 356)

4 (1)

11 (3)

Severity of stenosis — no. (%)
Mild

Combined Randomized and Observational Cohorts

P Value

Surgical
Group
(N = 394)

Nonsurgical
Group
(N = 240)

0.24

0.006
6 (2)

9 (4)

Moderate

131 (47)

151 (42)

161 (41)

121 (50)

Severe

143 (51)

194 (54)

227 (58)

110 (46)

Spinal instability

0

0

P Value

0

0

* Plus–minus values are means ±SD. Patients in the combined two cohorts were classified according to whether they received surgical treat
ment or nonsurgical treatment during the first 2 years of enrollment. Numbers of patients include only those who completed at least one
follow-up survey within 2 years after enrollment.
† Race or ethnic group was self-reported. Whites and blacks could be either Hispanic or non-Hispanic.
‡ This category includes patients who were receiving or had applications pending for workers’ compensation, Social Security benefits, or
other compensation.
§ The body-mass index is the weight in kilograms divided by the square of the height in meters.
¶ Other disorders included problems related to stroke, cancer, lung disorders, fibromyalgia, chronic fatigue syndrome, post-traumatic stress
disorder, alcohol or drug dependency, migraine, anxiety, or disorders of the liver, kidney, blood vessels, or nervous system.
‖ Scores on the Medical Outcomes Study 36-item Short-Form General Health Survey (SF-36) range from 0 to 100, with higher scores indi
cating less severe symptoms.
** The Oswestry Disability Index ranges from 0 to 100, with lower scores indicating less severe symptoms.
†† The Stenosis Frequency Index ranges from 0 to 24, with lower scores indicating less severe symptoms.
‡‡ The Stenosis Bothersomeness Index ranges from 0 to 24, with lower scores indicating less severe symptoms.
§§ The Low Back Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms.
¶¶ The Leg Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms.

over to undergo surgery had more self-rated disability, more psychological distress, worse symptoms, and a stronger treatment preference for
surgery at baseline than did patients who did not
opt for surgery. Patients in the surgical group
who crossed over to receive nonsurgical care were
more often not white, had less bothersome symptoms, less often rated their symptoms as worsening at enrollment, and had a stronger treatment
preference for nonsurgical care at baseline.
Main Treatment Effects

In the intention-to-treat analysis, a significant
treatment effect favoring surgery was seen at
2 years, with a mean difference in change from
baseline of 7.8 (95% confidence interval [CI], 1.5
to 14.1) on the SF-36 scale for bodily pain; at
earlier times, there was a smaller nonsignificant
effect in favor of surgery. However, at 2 years,
there were no significant differences between
the surgical group and the nonsurgical group on
the SF-36 scale for physical function (0.1; 95%
CI, −6.4 to 6.5) or on the Oswestry Disability Index (−3.5; 95% CI, −8.7 to 1.7) (Table 4).

n engl j med 358;8

In the as-treated analysis, the mean differences
in change from baseline in the randomized and
observational cohorts were similar at 2 years:
bodily pain, 11.7 (95% CI, 6.2 to 17.2) in the
randomized group versus 15.3 (95% CI, 10.4 to
20.2) in the observational group; physical function, 8.1 (95% CI, 2.8 to 13.5) in the randomized
group versus 13.6 (95% CI, 8.7 to 18.4) in the
observational group; and Oswestry Disability Index, −8.7 (95% CI, −13.3 to −4.0) in the randomized group versus −13.1 (95% CI, −16.9 to −9.2)
in the observational group (Fig. 2).
The global hypothesis test comparing the astreated effects in the randomized group and the
observational group over all time periods showed
no difference between the two cohorts (P = 0.93
for bodily pain, P = 0.67 for physical function, and
P = 0.60 for the Oswestry Disability Index).
Results from the intention-to-treat analysis
and the as-treated analysis of the two cohorts
are compared in Figure 2. The effects shown in
the as-treated analysis significantly favored surgery in both cohorts. In the combined analysis,
treatment effects were significant in favor of sur-

www.nejm.org

february 21, 2008

The New England Journal of Medicine
Downloaded from nejm.org at THOMAS JEFFERSON UNIVERSITY on June 19, 2012. For personal use only. No other uses without permission.
Copyright © 2008 Massachusetts Medical Society. All rights reserved.

801

The

n e w e ng l a n d j o u r na l

of

m e dic i n e

Table 2. Surgical Treatments, Complications, and Events.*
Randomized Cohort
(N = 155)

Variable

Observational Cohort
(N = 239)

Procedure — no./total no. (%)

P Value
0.49

Decompression only

137/154 (89)

209/235 (89)

6/154 (4)

14/235 (6)

11/154 (7)

12/235 (5)

5/155 (3)

11/239 (5)

0.68

53/152 (35)

90/235 (38)

0.57

L3–L4

115/152 (76)

157/235 (67)

0.081

L4–L5

140/152 (92)

218/235 (93)

0.97

L5–S1

60/152 (39)

89/235 (38)

0.83

Noninstrumented fusion
Instrumented fusion
Multilevel fusion — no./total no. (%)
Decompression level — no./total no. (%)
L2–L3

Levels decompressed — no./total no. (%)

0.92

None

3/155 (2)

4/239 (2)

1

33/155 (21)

54/239 (23)

2

47/155 (30)

78/239 (33)

≥3

72/155 (46)

103/239 (43)

Operation time — min

128.4±64.7

127.8±66.2

0.93

Blood loss — ml

338.5±527.1

295.6±312.6

0.31

Intraoperative transfusion

14/152 (9)

23/238 (10)

0.98

Postoperative transfusion

6/153 (4)

13/238 (5)

0.65

3.0±2.2

0.13

Blood replacement — no./total no. (%)

No. of days in hospital

3.5±2.6

Postoperative mortality — no./total no. (%)†
Within 6 wk

0/155

1/239 (<1)

0.83

Within 3 mo

0/155

1/239 (<1)

0.83

13/155 (8)

23/238 (10)

0.80

Other

1/155 (1)

2/238 (1)

0.71

None

141/155 (91)

213/238 (89)

0.76

Intraoperative complications — no./total no. (%)‡
Dural tear or spinal fluid leak

Postoperative complications or events — no./total no. (%)§

802

Wound hematoma

3/153 (2)

1/238 (<1)

0.34

Wound infection

3/153 (2)

5/238 (2)

0.79

Other

8/153 (5)

13/238 (5)

0.90

None

135/153 (88)

208/238 (87)

0.93
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Table 2. (Continued.)
Randomized Cohort
(N = 155)

Variable

Observational Cohort
(N = 239)

P Value

Additional surgery — no./total no. (%)¶
Any surgery
At 1 yr

6/157 (4)

15/243 (6)

0.29

At 2 yr

10/157 (6)

21/243 (9)

0.39

At 1 yr

3/155 (2)

2/241 (1)

At 2 yr

6/155 (4)

5/241 (2)

At 1 yr

0/155

0/239

At 2 yr

0/155

0/239

Recurrent stenosis or progressive spondylolisthesis

Pseudarthrosis or fusion exploration

Complication or other problem
At 1 yr

3/155 (2)

10/241 (4)

At 2 yr

4/155 (3)

11/241 (5)

New condition
At 1 yr

0/155

2/241 (1)

At 2 yr

1/155 (1)

5/241 (2)

* Plus–minus values are means ±SD. A total of 157 patients in the randomized cohort and 243 patients in the observational
cohort underwent surgery. Data are missing for patients in some categories, as indicated by varying denominators.
† One patient had a myocardial infarction.
‡ None of the following were reported: aspiration, nerve-root injury, operation at wrong level, and vascular injury.
§ This category includes all reported complications up to 8 weeks after surgery. None of the following were reported:
bone-graft complication, cerebrospinal fluid leak, paralysis, cauda equina injury, wound dehiscence, pseudarthrosis,
and nerve-root injury.
¶ Rates of repeated surgery at 1 and 2 years are Kaplan–Meier estimates. P values were calculated with the use of the logrank test.

gery for all primary and secondary outcome nonsurgical group improved only moderately durmeasures at each time point during the 2 years ing the 2-year period. The intention-to-treat re(Table 4).
sults must be viewed in the context of the substantial rates of nonadherence to assigned treatment. The pattern of nonadherence was striking
Dis cus sion
because both the surgical and the nonsurgical
In patients with imaging-confirmed spinal steno- groups were affected, unlike the results of many
sis without spondylolisthesis and leg symptoms studies involving surgical procedures.30 The mixpersisting for at least 12 weeks, surgery was su- ing of treatments owing to crossover can be experior to nonsurgical treatment in relieving symp- pected to create a bias toward the null.31 The
toms and improving function. In the as-treated large effects seen in the as-treated analysis and
analysis, the treatment effect for surgery was the characteristics of the crossover patients sugseen as early as 6 weeks, appeared to reach a gest that the intention-to-treat analysis underesmaximum at 6 months, and persisted for 2 years; timated the true effect of surgery.
it is notable that the condition of patients in the
This study provides an opportunity to compare
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Table 3. Significant Predictors of Treatment Received within 2 Years among Patients in the Randomized Cohort.*
Predictor

Assigned to Surgical Group
Surgery
(N = 89)

No Surgery
(N = 43)

80 (90)

Mental Component Summary score†

Assigned to Nonsurgical Group

P Value

Surgery
(N = 64)

No Surgery
(N = 82)

P Value

29 (67)

0.003

58 (91)

71 (87)

0.62

49.9±12.2

50.4±14.0

0.84

47.0±12.6

51.6±11.2

0.02

Oswestry Disability Index‡

44.6±18.2

38.9±18.8

0.10

46.7±18

39.4±16.2

0.01

Stenosis Frequency Index§

14.8±5.3

11.6±6.2

0.002

14.7±5.5

12.1±5.5

0.005

Stenosis Bothersomeness Index¶

15.0±4.9

12.0±6.0

0.002

15.3±5.5

12.6±6.1

0.005

Leg Pain Bothersomeness Scale‖

4.5±1.6

4.0±1.9

0.09

4.6±1.5

3.9±1.8

0.01

Very dissatisfied with symptoms — no. (%)

65 (73)

25 (58)

0.13

49 (77)

44 (54)

0.007

White race — no. (%)

Problem getting better or worse — no. (%)
Getting better

0.009

0.31

2 (2)

6 (14)

2 (3)

8 (10)

Staying about the same

27 (30)

18 (42)

22 (34)

28 (34)

Getting worse

57 (64)

19 (44)

38 (59)

46 (56)

Treatment preference — no. (%)

0.01

<0.001

Nonsurgical
Definitely

9 (10)

8 (19)

7 (11)

13 (16)

Probably

15 (17)

15 (35)

9 (14)

22 (27)

Not sure

31 (35)

13 (30)

15 (23)

36 (44)

Surgical
Definitely

11 (12)

0

17 (27)

5 (6)

Probably

23 (26)

7 (16)

16 (25)

5 (6)

* Plus–minus values are means ±SD. Numbers of patients include only those who completed at least one follow-up survey within 2 years after
enrollment.
† Scores on the Medical Outcomes Study 36-item Short-Form General Health Survey (SF-36) range from 0 to 100, with higher scores indicat
ing less severe symptoms.
‡ The Oswestry Disability Index ranges from 0 to 100, with lower scores indicating less severe symptoms.
§ The Stenosis Frequency Index ranges from 0 to 24, with lower scores indicating less severe symptoms.
¶ The Stenosis Bothersomeness Index ranges from 0 to 24, with lower scores indicating less severe symptoms.
‖ The Leg Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms.

results involving patients who were willing to par
ticipate in a randomized study (randomized co
hort) and those who were unwilling to participate in such a study (observational cohort).13‑16
These two cohorts were remarkably similar at
baseline. Other than treatment preference, the
only significant differences were small ones in
signs of nerve-root tension and the location of
stenosis. The two cohorts also had similar outcomes, without significant differences in the astreated analyses. Given these similarities, the
combined analyses are well justified. Although
these analyses are not based on randomized
treatment assignments, the results are strengthened by the use of specific inclusion and exclu-
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n engl j med 358;8

sion criteria, the sample size, and adjustment for
potentially confounding baseline differences.32
The characteristics of the patients were similar to those in previous studies, even though the
latter involved mixed-cohort patients (i.e., those
with or without spondylolisthesis). In our study,
the functional status of the patients at baseline
was similar to that of patients in the Maine
Lumbar Spine Study7,8 (SF-36 score, 34.8 and 35.0,
respectively) but worse than that in the study by
Malmivaara et al.10,11 (Oswestry Disability Index,
42.4 and 35.0, respectively).
In the as-treated analysis, the functional improvement in the surgical group at 1 year was
very similar to that in the Maine Lumbar Spine
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Table 4. Intention-to-Treat Analysis for the Randomized Cohort and Adjusted Analyses, According to Treatment Received, for the Randomized
Outcome

Baseline
Overall
Mean

At 6 Wk
Surgery

No Surgery

At 3 Mo

Treatment Effect
(95% CI)†

Mean Change

Surgery

No Surgery

Treatment Effect
(95% CI)†

Mean Change

Intention-to-treat analysis of randomized cohort
No. of patients

278

116

130

116

135

Bodily pain

31.9±1.1

11.2±2.4

7.9±2.2

3.3 (−3.2 to 9.8)

13.5±2.5

11.1±2.3

2.4 (−4.2 to 9.1)

Physical function

35.4±1.4

6.0±2.5

10.2±2.3

−4.2 (−10.8 to 2.4)

7.4±2.5

11.6±2.3

−4.2 (−10.9 to 2.6)

Oswestry Disability Index§

42.7±1.1

−6.5±2.0

−7.9±1.8

1.4 (−3.9 to 6.8)

−7.6±2.1

−8.1±1.9

0.5 (−5.0 to 6.0)

13.9±0.3

NA

NA

NA

−4.5±0.8

−3.8±0.7

−0.7 (−2.8 to 1.5)

Leg Pain Bothersomeness Index‖

4.3±0.1

NA

NA

NA

−1.5±0.3

−1.2±0.2

−0.3 (−1.0 to 0.4)

Low Back Pain Bothersomeness
Index**

4.0±0.1

NA

NA

NA

−0.6±0.2

−1.0±0.2

0.4 (−0.2 to 1.0)

Very or somewhat satisfied
with symptoms

5.0

22.0

27.9

−5.9 (−18.0 to 6.2)

38.1

33.7

4.3 (−9.6 to 18.2)

Very or somewhat satisfied
with care

NA

68.7

71.8

−3.1 (−15.9 to 9.7)

71.6

77.0

−5.4 (−18.0 to 7.2)

Self-rated major improve
ment in condition

NA

19.7

25.8

−6.1 (−18.0 to 5.9)

30.9

35.4

−4.5 (−18.2 to 9.3)

378

313

Primary outcome
SF-36‡

Secondary outcome
Stenosis Bothersomeness
Index¶

Satisfaction of patient (%)

As-treated analysis of randomized and observational cohorts††
No. of patients

803

398

370

Bodily pain

31.4±0.6

19.8±1.1

9.8±1.1

10.0 (7.3 to 12.7)

27.9±1.1

11.8±1.2

16.1 (13.1 to 19.1)

Physical function

34.9±0.8

17.8±1.1

8.7±1.1

9.1 (6.5 to 11.8)

24.8±1.2

10.0±1.2

14.8 (11.9 to 17.7)

Oswestry Disability Index§

43.2±0.6

−17.0±0.9

−6.8±0.9

14.4±0.2

NA

NA

NA

−8.6±0.4

−2.9±0.4

−5.7 (−6.7 to −4.6)

Leg Pain Bothersomeness Scale‖

4.3±0.1

NA

NA

NA

−2.7±0.1

−0.9±0.1

−1.8 (−2.1 to −1.5)

Low Back Pain Bothersomeness
Scale**

4.1±0.1

NA

NA

NA

−2.0±0.1

−0.8±0.1

−1.2 (−1.5 to −0.9)

Very or somewhat satisfied
with symptoms

5.7

64.0

18.5

45.5 (39.2 to 51.8)

61.9

22.8

39.1 (32.0 to 46.1)

Very or somewhat satisfied
with care

NA

90.1

67.5

22.7 (16.8 to 28.5)

90.1

71.3

18.7 (12.6 to 24.9)

Self-rated major improve
ment in condition

NA

72.0

18.2

53.8 (48.0 to 59.6)

72.0

20.0

52.0 (45.6 to 58.3)

Primary outcome
SF-36‡

−10.3 (−12.5 to −8.1) −21.4±0.9

−7.6±1.0 −13.8 (−16.2 to −11.3)

Secondary outcome
Stenosis Bothersomeness
Index¶

Satisfaction of patient (%)

* Plus–minus values are means ±SE. Values in the as-treated analysis have been adjusted for age, sex, the presence or absence of stomach or
joint disorders, the presence or absence of pain on straight-leg raising or femoral-nerve tension signs, smoking status, patient-assessed
health trend, income, other compensation, body-mass index, baseline score for the outcome variable, and center. NA denotes not available.
† The treatment effect is the difference in the mean change from baseline between the surgical group and the nonsurgical group.
‡ The SF-36 scores range from 0 to 100, with higher scores indicating less severe symptoms.
§ The Oswestry Disability Index ranges from 0 to 100, with lower scores indicating less severe symptoms.
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and Observational Cohorts Combined.*
At 6 Mo
Surgery

No Surgery

At 1 Yr

Treatment Effect
(95% CI)†

Surgery

Mean Change

No Surgery

At 2 Yr
Treatment Effect
(95% CI)†

Mean Change

120

135

120

21.0±2.2

16.1±2.1

4.9 (−1.2 to 10.9)

17.6±2.3

15.1±2.2

2.5 (−3.7 to 8.6)

−14.6±1.9 −13.7±1.7

−0.9 (−5.9 to 4.1)

Surgery

No Surgery

Treatment
Effect (95% CI)†

Mean Change

126

108

113

23±2.3

17.5±2.2

5.5 (−0.7 to 11.7)

23.4±2.3

15.6±2.2

7.8 (1.5 to 14.1)

18.0±2.3

16.4±2.2

1.6 (−4.8 to 7.9)

17.1±2.4

17.1±2.3

0.1 (−6.4 to 6.5)

−14.9±1.9 −12.7±1.8

−2.2 (−7.4 to 2.9)

−16.4±1.9 −12.9±1.8

−3.5 (−8.7 to 1.7)

NA

NA

NA

−6.1±0.7

−4.9±0.7

−1.2 (−3.2 to 0.8)

−6.3±0.7

−5.6±0.7

−0.7 (−2.7 to 1.3)

NA

NA

NA

−2.3±0.2

−1.7±0.2

−0.6 (−1.3 to 0)

−2.2±0.2

−1.8±0.2

−0.3 (−1.0 to 0.3)

NA

NA

NA

−1.3±0.2

−1.3±0.2

−1.3±0.2

−1.6±0.2

0.3 (−0.2 to 0.9)

49.9

38.3

11.7 (−0.8 to 24.1)

53.4

40.7

12.8 (−0.3 to 25.8)

53.1

45.0

8.1 (−5.3 to 21.5)

85.0

73.1

11.9 (1.9 to 21.9)

81.4

69.3

12.0 (0.8 to 23.2)

76.2

68.5

7.6 (−4.5 to 19.7)

49.0

46.2

55.3

44.2

11.1 (−2.1 to 24.2)

50.7

45.0

5.8 (−7.8 to 19.3)

256

271

302

230

335

198

29.5±1.3

12.9±1.2

16.6 (13.3 to 19.9)

28.0±1.2

13.5±1.4

14.6 (11.2 to 18)

26.9±1.2

13.3±1.4

26.9±1.3

10.6±1.3

16.3 (13.1 to 19.6)

26.5±1.2

10.5±1.4

15.9 (12.6 to 19.3)

23.0±1.3

11.8±1.4

11.1 (7.6 to 14.7)

−22.9±1.0

−8.8±1.0

−14.1 (−16.8 to −11.4) −21.4±1.0

−8.9±1.1

−12.5 (−15.3 to −9.8) −20.5±1.0

−9.3±1.2

−11.2 (−14.1 to −8.3)

NA

NA

NA

−8.2±0.3

−3.9±0.4

−4.4 (−5.4 to −3.3)

−7.8±0.4

−4.4±0.4

−3.4 (−4.5 to −2.3)

NA

NA

NA

−2.6±0.1

−1.4±0.1

−1.2 (−1.5 to −0.9)

−2.5±0.1

−1.4±0.1

−1.1 (−1.4 to −0.7)

NA

NA

NA

−2.0±0.1

−1.0±0.1

−1.0 (−1.3 to −0.7)

−2.0±0.1

−1.1±0.1

−1.0 (−1.3 to −0.6)

62.8

26.3

36.5 (28.6 to 44.4)

67.6

29.2

38.4 (30.3 to 46.5)

68.2

29.6

38.7 (30.0 to 47.3)

90.8

67.3

23.5 (16.7 to 30.3)

86.1

69.1

17.0 (9.6 to 24.4)

83.1

67.0

16.1 (7.8 to 24.3)

67.0

24.9

42.1 (34.5 to 49.6)

68.8

25.4

43.4 (35.7 to 51.1)

62.9

28.7

34.1 (25.6 to 42.6)

2.8 (−10.0 to 15.5)

0 (−0.5 to 0.6)

13.6 (10.0 to 17.2)

¶ The Stenosis Bothersomeness Index ranges from 0 to 24, with lower scores indicating less severe symptoms.
‖ The Leg Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms.
** The Low Back Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms.
†† The number of patients in the as-treated analyses reflects the number of patients contributing to the estimate in a given period with the
use of the longitudinal-modeling strategy (explained in the Methods section) and may not correspond to the number shown for each visit
time in Figure 1.
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Study (26.5 and 27.0, respectively) but greater
than in the study by Malmivaara et al. (Oswestry
Disability Index, −21.4 and −11.3, respectively).
Functional improvement in the nonsurgical group
was greater in our study than in the previous
studies, with a change of 10.5 in the SF-36 physical
function score at 1 year, as compared with 1.0
in the Maine Lumbar Spine Study, and a change
of 9.3 in the Oswestry Disability Index at 2 years,
as compared with 4.5 in the study by Malmivaara et al. The greater improvements in our
study, compared with those in the study by Mal
mivaara et al., may be related to differences in
the selection of patients. In the study by Malmivaara et al., patients with moderate spinal stenosis were specifically selected, whereas in our
study, we attempted to enroll patients with spinal
stenosis who were surgical candidates.
In the as-treated analysis, we can directly compare the estimates of treatment effect with those
of the previous studies. The estimated 1-year
treatment effects for surgery were smaller in our
study than in the Maine Lumbar Spine Study
(changes in bodily pain of 14.6 and 30.4, respectively, and in physical function of 15.9 and 25.5,
respectively). However, in the Maine Lumbar
Spine Study, treatment effects for baseline differences between the study groups were not adjusted, which probably explains these discrepancies. At 1 year, the estimated treatment effects
were similar in our study and the study by Malmivaara et al.: Oswestry Disability Index, −12.5 and
−11.3, respectively; leg pain, 17% (on a 7-point
scale) and 15% (on an 11-point scale); and back
pain, 14% (on a 7-point scale) and 21% (on an
11-point scale).
It is interesting that among patients who underwent surgery, the magnitude of the mean
changes in patients with spinal stenosis was
nearly identical to that in the patients with degenerative spondylolisthesis at 2 years: bodily pain,
26.9 and 29.9, respectively; physical function, 23.0
and 26.6; Oswestry Disability Index, −20.5 and
−24.2; and bothersomeness of symptoms, −7.8
and −8.9.16 The treatment effects in these studies of spinal stenosis were larger than those in
the observational study of patients with intervertebral disk herniation because of strong improvements in the nonsurgical group of patients
with intervertebral disk herniation that were not
seen in either stenosis group.14-16
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There was little evidence of harm from either
treatment. Often patients fear they will get worse
without surgery, but this was not the case for the
majority of patients in the nonsurgical group,
who, on average, showed small improvements in
all outcomes. The 1-year rate of reoperation for
recurrent stenosis was 1.3%, a rate similar to
those reported by Malmivaara et al. (2%) and by
the Maine Lumbar Spine Study (1.2%). At 2 years,
mortality was nearly the same in the two study
groups and was lower than actuarial projections.
The postoperative death rate of 0.3% and the
overall postoperative complication rate of 12%
were slightly better than the reported Medicare
rates in patients with spinal stenosis who did not
undergo spinal fusion (death rate, 0.8%; rate of
complications, 14%).1 However, higher rates of
complications have been reported with increasing
age and coexisting medical conditions.33
The primary limitation of our study was the
marked degree of nonadherence to randomized
treatment. This factor reduced the power of the
intention-to-treat analysis to show treatment effects, though there was still a significant treatment effect for the measure of bodily pain at
2 years. The as-treated analyses do not share the
strong protection from confounding that exists
for the intention-to-treat analyses. However, these
analyses were carefully adjusted for important
baseline covariates and yielded results similar to
those of previous studies. The characteristics of
the crossover patients were as one might expect:
those with severe symptoms and a preference for
surgery crossed over into the surgical group, and
vice versa.
Another limitation was the heterogeneity of
the nonsurgical treatments. Given the limited
evidence regarding efficacy of most nonsurgical
treatments for spinal stenosis and individual variability in response, the creation of a limited,
fixed protocol for nonsurgical treatment was
neither clinically feasible nor generalizable. The
flexible treatment protocols allowed for individualization of nonsurgical treatment plans, reflect
current practice among multidisciplinary spine
practices, and were consistent with published
guidelines.34,35 However, we did not assess the
effect of surgery versus any specific nonsurgical
treatment.
In conclusion, in the as-treated analysis, if we
combine the randomized and observational co-
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horts, carefully adjusting for potentially confounding baseline factors, patients with spinal
stenosis without degenerative spondylolisthesis
who underwent surgery showed significantly
greater improvement in pain, function, satisfaction, and self-rated progress than did patients
who were treated nonsurgically.
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In addition to the authors, the following investigators participated in the study, with institutions listed in order from highest to lowest
enrollment of patients: William Beaumont Hospital, Royal Oak, MI: G. Bradley, M. Lurie, J. Fischgrund, D. Montgomery, L. Kurz, E. Truumees; Washington University, St. Louis: L. Lenke, G. Stobbs, A. Margherita, H. Prather, K. Bridwell, K.S. Riew, C. Lauryssen, B. Taylor, J.
Metzler; Dartmouth Medical School, Lebanon, NH: J. Forman, W. Abdu, B. Butler-Schmidt, J.J. Hebb, P. Ball, P. Bernini, H. Magnadottir, R.
Rose, R. Roberts, R. Diegel, S. Banerjee, R. Beasely; Emory University, Atlanta: S. Lashley, J. Heller, H. Levy, S.T. Yoon, M. Schaufele, W.
Horton; Rothman Institute at Thomas Jefferson Hospital, Philadelphia: C. Simon, M. Freedman, O’Brien, S. Dante, T. Conliffe; University Hospitals
of Cleveland and Case Western Reserve University, Cleveland: S. Emery, C. Furey, K. Higgins, J.X. Yoo, H. Bohlman, E.B. Marsolais, R.S. Krupkin;
Hospital for Special Surgery, New York: B. Green, O. Boachie-Edjei, J. Farmer; Nebraska Foundation for Spinal Research, Omaha: M. Longley, N.
Fullmer, A.M. Fredericks, J. Fuller, R. Woodward, J. McClellan, E. Phillips, T. Burd, P. Bowman; University of California at San Francisco, San
Francisco: P. Malone, D. Bradford, S. Deviren, P. Weinstein, T. Smith; Hospital for Joint Diseases, New York: T. Errico, A. Lee, J. Goldstein, J.
Spivak, R. Perry, J. Bendo, R. Moskovich; Rush–Presbyterian–St. Luke’s Medical Center, Chicago: G. Andersson, M. Hickey, E. Goldberg, F.
Phillips, R. Massimino, S. Petty; Kaiser Permanente, Oakland, CA: H. Goldberg; Maine Spine and Rehabilitation, Scarborough: R. Keller.
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